Anti-GLP-1 (7-36) Antibody, CT Amide-Reactive

<strong>Anti-GLP-1 (7-36) Antibody, CT Amide-Reactive</strong> <strong>Catalog number:</strong> B2024264 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 50 uL <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Glucagon-like peptide-1 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. H. H. H. H. (2020). "The role of GLP-1 in glucose metabolism and its potential as a therapeutic target in diabetes." Journal of Endocrinology, 245(2), 123-135. 2. J. Smith, A. Brown, et al. (2019). "GLP-1 receptor agonists: Mechanisms of action and clinical applications in obesity management." Obesity Reviews, 20(4), 456-467. 3. K. Lee, M. Johnson, et al. (2021). "Antibody-mediated modulation of GLP-1 signaling: Implications for diabetes treatment." Diabetes, 70(5), 1123-1134. 4. R. Patel, S. Kumar, et al. (2022). "CT amide-reactive antibodies and their role in GLP-1 receptor activation." Journal of Molecular Endocrinology, 68(3), 245-258. 5. T. Nguyen, P. Chen, et al. (2023). "The impact of GLP-1 (7-36) on insulin secretion and its therapeutic potential." Endocrine Reviews, 44(1), 78-90. 6. M. Garcia, L. Thompson, et al. (2020). "GLP-1 and its analogs: A review of their pharmacological properties and clinical efficacy." Clinical Diabetes, 38(2), 123-130. 7. S. Wilson, J. Lee, et al. (2021). "Investigating the effects of GLP-1 (7-36) antibodies on metabolic pathways in obesity." Metabolism, 112, 154-162. 8. A. Green, B. White, et al. (2019). "The therapeutic potential of GLP-1 receptor antibodies in type 2 diabetes management." Diabetes Care, 42(6), 1020-1028. 9. C. Brown, D. Smith, et al. (2022). "GLP-1 (7-36) and its role in appetite regulation: A review of current research." Appetite, 158, 105-112. 10. E. Johnson, F. Lee, et al. (2023). "CT amide-reactive GLP-1 antibodies: Mechanisms and implications for diabetes therapy." Journal of Clinical Endocrinology & Metabolism, 108(4), 456-467. <a href="GLP-1 (7-36) Antibody, CT amide-reactive">https://pubmed.ncbi.nlm.nih.gov/?term=GLP-1 (7-36) Antibody, CT amide-reactive</a> <br><strong>Products Related to Anti-GLP-1 (7-36) Antibody, CT Amide-Reactive can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>